Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

2019 SOHO Update on AML: FLT3 and IDH1/2 Inhibitors, Venetoclax, Antibodies, CAR-T CPIs, CD70 Ab / CD47 Ab, and APR 246 for p53-Mutated MDS/AML

0 views
December 9, 2019
Comments 0
Login to view comments. Click here to Login